Raymond James initiates American Healthcare REIT stock at strong buy on Trilogy partnership
Raymond James initiated American Healthcare REIT (AHR) with a Strong Buy rating and $62 price target, citing its partnership with Trilogy. AHR trades at $52.52 with a $12.25B market cap, 29.8% YTD return, 16.9% revenue growth, and 3.81% dividend yield. Q2 2026 results showed $0.54 normalized FFO/share, $674.25M revenue, and $0.16 GAAP EPS. KeyBanc raised its target to $68, while Citizens maintained Outperform and $65 target.


